Patents-Review.com
ClassID:

21111 ⎘

A61K39/125 - CPC Classification

Classification description:

Medicinal preparations containing antigens or antibodies; Viral antigens Picornaviridae, e.g. calicivirus

Sub-classes:
Recent Application in this class:
#1
20260137769
2026-05-21

NUCLEIC ACID MOLECULES AND USES THEREOF

 #2
20260124291
2026-05-07

RHINOVIRUS MRNA VACCINE

 #3
20260077037
2026-03-19

CATIONIC LIPID BASED COMPOSITION, FORMULATION AND USE FOR NUCLEIC ACID VACCINE DELIVERY AND PREPARATION THEREOF

 #4
20260069673
2026-03-12

BIVALENT INACTIVATED EV71-CA16 VACCINE, METHOD FOR PREPARING THE SAME, AND USE THEREOF

 #5
20260014251
2026-01-15

COMPOSITIONS, METHODS, AND USES FOR POLYNUCLEOTIDE FORMULATIONS FOR DRYING AND PROLONGED STORAGE

 #6
20250352634
2025-11-20

Coxsackievirus B Compositions and Methods Of Use Thereof

 #7
20250269007
2025-08-28

NUCLEIC ACID MOLECULES AND USES THEREOF

 #8
20250134993
2025-05-01

GLYCATED CHITOSANS FOR TREATMENT OF VIRAL INFECTIONS

 #9
20250134983
2025-05-01

VIRAL VECTOR DELIVERY SYSTEM FOR BOTH RESPIRATORY AND DIGESTIVE TRACTS OF PIGS AND APPLICATION THEREOF

 #10
20250064915
2025-02-27

NUCLEIC ACID MOLECULES AND USES THEREOF

 #11
20250057933
2025-02-20

Rhinovirus Vaccine

 #12
20250018024
2025-01-16

COMPOSITIONS AND METHODS FOR PROTEIN EXPRESSION WITH RNA

 #13
20250009867
2025-01-09

COXSACKIEVIRUS B4 STRAIN AND APPLICATION THEREOF

 #14
20240408189
2024-12-12

MULTI-CBV VACCINE FOR PREVENTING OR TREATING TYPE I DIABETES

 #15
20240398865
2024-12-05

TUMOR AVATAR VACCINE COMPOSITIONS AND USES THEREOF

 #16
20240350615
2024-10-24

GENERAL AFFINITY EPITOPE POLYPEPTIDE FOR HUMAN RHINOVIRUS, AND ANTIBODY AND USES THEREOF

 #17
20240269256
2024-08-15

COMPOSITIONS AND METHODS FOR ENHANCED ANTIGEN BINDING PROTEINS

 #18
20240261386
2024-08-08

Coxsackievirus 83 Vaccine

 #19
20240238401
2024-07-18

SOLID COMPOSITION, FREEZE-DRYING METHOD AND GLASS VIAL

 #20
20240156942
2024-05-16

Peptide of Norovirus Origin, Polynucleotide, Antibody, Composition, Method for Identifying Neutralizing Epitope for Norovirus

 #21
20240100145
2024-03-28

VLP ENTEROVIRAL VACCINES

 #22
20240066112
2024-02-29

NOROVIRUS VIRUS-LIKE PARTICLE, IMMUNE COMPOSITION, OR KIT, AND USE THEREOF

 #23
20230416308
2023-12-28

ENCAPSULATED RNA REPLICONS AND METHODS OF USE

 #24
20230338503
2023-10-26

PARENTERAL NOROVIRUS VACCINE FORMULATIONS

 #25
20230330208
2023-10-19

Immunogenic Human Rhinovirus (HRV) Composition

 #26
20230285542
2023-09-14

Coronavirus Vaccine

 #27
20230256078
2023-08-17

IMMUNOGENIC COMPOSITION AND VACCINE FOR GENERATING AN IMMUNE RESPONSE TO NOROVIRUS

 #28
20230233669
2023-07-27

RECOMBINANT ENTEROVIRUSES AND USES THEREOF

 #29
20220354943
2022-11-10

Therapeutic Agent Effectiveness and its Route of Adminstration

 #30
20220313812
2022-10-06

SENECAVIRUS A IMMUNOGENIC COMPOSITIONS AND METHODS THEREOF

 #31
20220280529
2022-09-08

INACTIVATION OF PATHOGENS USING METAL-BASED COORDINATION COMPLEXES, AND METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING MICROBIAL AND/OR VIRAL INFECTIONS

 #32
20220249650
2022-08-11

SENECAVIRUS A VIRUS STRAINS AND IMMUNOGENIC COMPOSITIONS THEREFROM

 #33
20220031832
2022-02-03

Recombinant nucleic acid of Seneca valley virus, recombinant vaccine strain and preparation method and use thereof

 #34
20210401966
2021-12-30

Compositions comprising a norovirus nucleic acid and methods of use thereof

 #35
20210393768
2021-12-23

COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING VIRUS INFECTION

 #36
20210393554
2021-12-23

NANOEMULSION COMPOSITIONS HAVING ENHANCED PERMEABILITY

 #37
20210299240
2021-09-30

Composite polypeptide monomer, aggregate of said composite polypeptide monomer having cell penetration function, and norovirus component vaccine for subcutaneous, intradermal, percutaneous, or intramuscular administration and having said aggregate as effective component thereof

 #38
20210220465
2021-07-22

Multi-CBV vaccine for preventing or treating type I diabetes

 #39
20210162040
2021-06-03

Triple vaccine against and avian encephalomyelitis virus and fowl pox virus

 #40
20210085780
2021-03-25

Immunogenic Human Rhinovirus (HRV) Composition

 #41
20210085778
2021-03-25

Parenteral norovirus vaccine formulations

 #42
20210023196
2021-01-28

Multi-CBV vaccine for preventing or treating type 1 diabetes

 #43
20210000941
2021-01-07

Immunogenic composition and vaccine for generating an immune response to norovirus

 #44
20200331949
2020-10-22

D-glycero-B-D-heptose 1-phosphate (HMP) conjugates and use for targeted immune modulation

 #45
20200317739
2020-10-08

Recombinant polypeptides derived from FBP1 and FBP2 and uses of the same

 #46
20200306362
2020-10-01

Senecavirus a immunogenic compositions and methods thereof

 #47
20200172878
2020-06-04

Attenuated porcine sapelovirus strain and immunogenic compositions therefrom

 #48
20200000908
2020-01-02

Multi-CBV vaccine for preventing or treating type I diabetes

 #49
20190247488
2019-08-15

EXPRESSION CASSETTES AND METHODS FOR OBTAINING ENTEROVIRUS VIRUS-LIKE PARTICLES

 #50
20190240314
2019-08-08

Purification of recombinant EV71 virus-like particle and method for preparing vaccine thereof

 #51
20190224304
2019-07-25

CHIMERIC ENTEROVIRUS VIRUS-LIKE PARTICLES

 #52
20190209675
2019-07-11

Multi-CBV vaccine for preventing or treating type I diabetes

 #53
20190192592
2019-06-27

Live attenuated recombinant HMPV with mutations in PDZ motifs of M2-2 protein, vaccine containing and use thereof

 #54
20190125857
2019-05-02

Artificial nucleic acid molecules encoding a norovirus antigen and uses thereof

 #55
20190125853
2019-05-02

Norovirus vaccine formulations

 #56
20190112341
2019-04-18

Picornavirus-like particle production in plants

 #57
20190076519
2019-03-14

Immunogenic rhinovirus peptides

 #58
20180305422
2018-10-25

Recombinant polypeptides derived from FBP1 and FBP2 and uses of the same

 #59
20180271971
2018-09-27

Antigens and vaccines directed against human enteroviruses

 #60
20180243400
2018-08-30

Antigens and vaccines directed against human enteroviruses

 #61
20180243399
2018-08-30

FCV recombinant vaccines and uses thereof

 #62
20180214538
2018-08-02

Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus

 #63
20180195048
2018-07-12

METHODS FOR PRODUCING VIRUS FOR VACCINE PRODUCTION

 #64
20180185468
2018-07-05

Parenteral norovirus vaccine formulations

 #65
20180169215
2018-06-21

Multivalent enterovirus vaccine compositions and uses related thereto

 #66
20180163182
2018-06-14

Processes for production and purification of nucleic acid-containing compositions

 #67
20180125965
2018-05-10

Hand, foot, and mouth vaccines and methods of manufacture and use thereof

 #68
20180064802
2018-03-08

Immunogenic Human Rhinovirus (HRV) Composition

 #69
20180057541
2018-03-01

antigens and methods of use

 #70
20170305973
2017-10-26

Rhinovirus C immunogenic peptides

 #71
20170290905
2017-10-12

VACCINE

 #72
20170281748
2017-10-05

Multi-CBV vaccine for preventing or treating type I diabetes

 #73
20170196970
2017-07-13

Adjuvant for mucosal vaccine

 #74
20170056491
2017-03-02

Adenoviral vector-based vaccine against enterovirus infection

 #75
20160271242
2016-09-22

Subunit vaccine platform based on multimeric ribonucleoproteins comprising nucleoproteins of a non-segmented negative-strand RNA virus as carriers of heterologous polypeptides

 #76
20160228540
2016-08-11

Nasal mucosal vaccine composition

 #77
20160185826
2016-06-30

VIRUS-LIKE PARTICLE VACCINES

 #78
20160175425
2016-06-23

Method for rapidly designing pharmaceutical preparations for preventing viral infection

 #79
20160166675
2016-06-16

EV71 virus-like particles and preparation method and application thereof

 #80
20160095916
2016-04-07

Induction of cross-reactive cellular response against rhinovirus antigens

 #81
20160022804
2016-01-28

Immunogenic human rhinovirus (HRV) compositions

 #82
20160022803
2016-01-28

Vaccine

 #83
20160008455
2016-01-14

Norovirus vaccine formulations

 #84
20160000899
2016-01-07

Parenteral norovirus vaccine formulations

 #85
20150359871
2015-12-17

Immunogenic compositions comprising silicified virus and methods of use

 #86
20150225462
2015-08-13

Picornavirus-like particle production in plants

 #87
20150196487
2015-07-16

Vaccine formulations comprising saponin-containing adjuvants

 #88
20150140027
2015-05-21

Antigens and vaccines directed against human enteroviruses

 #89
20150056244
2015-02-26

Antigens and Vaccines Directed Against Human Enteroviruses

 #90
20150044257
2015-02-12

BACULOVIRUS-BASED ENTEROVIRUS 71 VLP AS A VACCINE

 #91
20150037355
2015-02-05

Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus

 #92
20140341923
2014-11-20

Human Rhinovirus (HRV) Antibodies

 #93
20140335047
2014-11-13

Drug delivery product and methods

 #94
20140328873
2014-11-06

Norovirus immunogens and related materials and methods

 #95
20140328797
2014-11-06

HUMAN RHINOVIRUS (HRV) ANTIBODIES

 #96
20140286994
2014-09-25

Norovirus vaccine formulations

 #97
20140255425
2014-09-11

Multi-CBV Vaccine for Preventing or Treating Type I Diabetes

 #98
20140161833
2014-06-12

Neutralizing immunogen (NimIV) of rhinovirus and its uses for vaccine applications

 #99
20140065185
2014-03-06

Mucosal immunization

 #100
20130344108
2013-12-26

Inactivated poliovaccine

 #101
20130273148
2013-10-17

Norovirus vaccine formulations

 #102
20130273147
2013-10-17

Method of conferring a protective immune response to Norovirus

 #103
20130273105
2013-10-17

Norovirus vaccine formulations

 #104
20130273102
2013-10-17

Parenteral norovirus vaccine formulations

 #105
20130273090
2013-10-17

Antigen-Norovirus P-domain monomers and dimers, antigen Norovirus P-particle molecules, and methods for their making and use

 #106
20130164330
2013-06-27

Methods and Compositions for Treatment of Hematologic Cancers

 #107
20130095134
2013-04-18

Stabilized virus like particles having enhanced mucosal immunogenicity

 #108
20130052163
2013-02-28

Human rhinovirus (HRV) antibodies

 #109
20120177686
2012-07-12

VACCINE FOR THE PREVENTION OF ACUTE LYMPHOBLASTIC LEUKEMIA

 #110
20120156243
2012-06-21

Norovirus vaccine formulations

 #111
20120121710
2012-05-17

Mucosal Immunization

 #112
20120093884
2012-04-19

Norovirus capsid and rotavirus VP6 protein for use as combined vaccine

 #113
20120093861
2012-04-19

NOROVIRUS VACCINE FORMULATIONS

 #114
20120045468
2012-02-23

Immunogenic compositions and uses thereof

 #115
20120027777
2012-02-02

LJUNGAN VIRUS WITH IMPROVED REPLICATION CHARACTERISTICS

 #116
20120003240
2012-01-05

Enterovirus Vaccines for Preventing or Treating Type 1 Diabetes (III)

 #117
20120003239
2012-01-05

Enterovirus Vaccines for Preventing and Treating Type 1 Diabetes (II)

 #118
20120003238
2012-01-05

Enterovirus Vaccines for Preventing or Treating Type 1 Diabetes (I)

 #119
20110318383
2011-12-29

Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing development of calicivirus disease

 #120
20110300149
2011-12-08

LJUNGAN VIRUS

 #121
20110150770
2011-06-23

MULTIVALENT VACCINE AGAINST PORCINE TESCHOVIRUS AND OTHER DISEASE CAUSING ORGANISMS IN SWINE

 #122
20110129494
2011-06-02

Vaccine formulations comprising saponin-containing adjuvants

 #123
20110002943
2011-01-06

USE OF ENTEROVIRUS FOR DIAGNOSTICS, TREATMENT AND PREVENTION OF DISEASE

 #124
20100322962
2010-12-23

Antigen-norovirus P-domain monomers and dimers, antigen-norovirus P-particle molecules, and methods for their making and use

 #125
20100297169
2010-11-25

Neutralizing immunogen (NimIV) of rhinovirus and its use for vaccine applications

 #126
20100266636
2010-10-21

METHOD OF CONFERRING A PROTECTIVE IMMUNE RESPONSE TO NOROVIRUS

 #127
20100221357
2010-09-02

Drug delivery product and methods

 #128
20100041023
2010-02-18

Inactivated FCV vaccines

 #129
20090162837
2009-06-25

Inactivated FCV vaccines

 #130
20090041795
2009-02-12

Synthetic replikin peptides against pathogenic infection of invertebrates in aquaculture

 #131
20080299152
2008-12-04

Norovirus vaccine formulations

 #132
20080286308
2008-11-20

Pathogenic Bovine Enterovirus, Vaccines, and Diagnostic Methods

 #133
20080193479
2008-08-14

Methods and compositions for treatment of hematologic cancers

 #134
20080124359
2008-05-29

Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing calicivirus infection or disease

 #135
20080063663
2008-03-13

Hemorrhagic feline calicivirus

 #136
20070280964
2007-12-06

Compositions and methods useful for modulating immunity, enhancing vaccine efficacy, decreasing morbidity associated with chronic FHV-1 infections, and preventing or treating conjunctivitis

 #137
20070098744
2007-05-03

Probiotic enterococci for improved immunity

 #138
20070031450
2007-02-08

Stabilizers for veterinary vaccines

 #139
20060240466
2006-10-26

Prevention of type 1 diabetes and other non-polio enterovirus diseases

 #140
20060160101
2006-07-20

Inactivated FCV vaccines

 #141
20060057159
2006-03-16

Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing calicivirus infection or disease

 #142
20050281781
2005-12-22

Drug delivery product and methods

 #143
20050232948
2005-10-20

Process for making an adjuvanted vaccine comprising host albumin

 #144
20050208073
2005-09-22

Vaccine against feline calicivirus

 #145
20050152911
2005-07-14

Norovirus monoclonal antibodies and peptides